Connecting to SEC EDGAR… PricingSign in
← All filings

BIVIW

Biovie Inc. SEC filings
Pharmaceutical Preparations · Nasdaq, Nasdaq · Incorporated in NV
On the radar right now · 0
Nothing in the live feed for BIVIW right now.
Filing history
2026-11-06
Quarterly report 10-Q
Filing ↗
2026-11-06
Current report 8-K
Material agreementShare sale (dilution)Reg FD disclosure
BioVie prices $4.74 million registered direct offering and concurrent private placement
Filing ↗
2026-11-06
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-11-05
Prospectus 424B5
Filing ↗
2026-11-05
Prospectus 424B5
Filing ↗
2026-11-04
Prospectus 424B5
Filing ↗
2026-09-28
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-09-14
Current report 8-K
Material agreement
Filing ↗
2026-09-14
Prospectus 424B5
Filing ↗
2026-09-03
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-28
Insider trade 4
Filing ↗
2026-08-28
Insider trade 4
Filing ↗
2026-08-28
Insider trade 4
Filing ↗
2026-08-28
Insider trade 4
Filing ↗
2026-08-19
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-14
S-1/A S-1/A
Filing ↗
2026-08-13
Annual report 10-K
Filing ↗
2026-08-07
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-07
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-07
FWP FWP
Filing ↗
2026-08-06
FWP FWP
Filing ↗
2026-08-06
FWP FWP
Filing ↗
2026-08-06
S-1/A S-1/A
Filing ↗
2026-08-06
Current report 8-K
Reg FD disclosure
Filing ↗
2026-07-31
S-1/A S-1/A
Filing ↗
2026-07-17
Registration (share sale/IPO) S-1
Filing ↗
2026-06-29
EFFECT EFFECT
Filing ↗
2026-06-18
Shelf registration (future share sales) S-3
Filing ↗
2026-06-11
DRS DRS
Filing ↗
2026-05-11
Quarterly report 10-Q
Filing ↗
2026-03-25
5%+ stake, may push for changes SCHEDULE 13D
Filing ↗
2026-02-06
Quarterly report 10-Q
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗
2026-01-09
Insider trade 4
Filing ↗